USFDA flags J&J vaccine for neurological disorder

WASHINGTON—The US Food and Drug Administration updated its warning labels Monday for the Johnson & Johnson COVID-19 vaccine to include information about an observed “increased risk” of a rare neurological disorder called Guillain-Barre Syndrome (GBS). Officials have identified 100 reports of GBS after 12.5 million doses administered. Of these, 95 were serious and required hospitalization with one death. GBS is a neurological disorder in which the body’s immune system damages nerve cells, causing muscle weakness or, in the most severe cases, paralysis.